On 23 September 2019, over 40 HKAPI members attended the “Post-VHIS Insurance Market” seminar held at the Duke of Windsor Social Service Building in Wanchai.
45 people showed up at the last episode of the Precision Medicine Series. This episode centered on the status quo and challenges faced by the industry and the regulator from the regulatory and legal perspective, worldwide and in Hong Kong, as the trend of precision medicine arrives.
This was the third seminar jointly organized by The University of Hong Kong, The University of Macau as well as the Pharmaceutical Society of Macao, supported and sponsored by the HKAPI.
Attended by about 50 members, Part 2 of the “Precision Medicine Seminar Series” was an intensive panel discussion centered on discussing the opportunities and challenges of commercialization of precision medicine as well as its commercial applications.
Organized by the HKAPI R&D Ecosystem Taskforce and supported by Baker McKenzie, the first seminar of the “Precision Medicine Seminar Series” was attended by around 50 members at Baker McKenzie’s new office in Quarry Bay.
To share findings from a recently conducted Patient Support Program research and to build a platform for stakeholders to exchange point of view, the HKAPI organized a sharing session for member companies and their collaborating partners on May 17, 2019.
On 8 May 2019, a total of 42 participants from the HKAPI, InvestHK and Hong Kong Science Park attended the “Why Invest in Hong Kong” Seminar held at the Baker McKenzie Office in Quarry Bay.
More than 60 representatives of member companies were guided through Macao's drug advertising rules in a sharing session held at Hong Kong Arts Centre' s theatre in Wan Chai on 11th December 2017.
Veteran journalist Chris Yeung told HKAPI members in a public affairs workshop on October 25, 2017 that Hong Kong politics is getting more complicated, as the government and many stakeholders have to take the China factor into consideration when making key decisions.